HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperventilation and ergonovine tests in Prinzmetal's variant angina: comparative sensitivity and relation with the activity of the disease.

Abstract
Hyperventilation (HV) and ergonovine (E) tests were carried out in a group of 32 patients with variant angina to compare their sensitivity and to correlate the results with the activity of the disease. The HV test was positive in 84% of the patients and E in 94% of them; the percentage of positive responses to HV was similar to that to E (96% vs 100%) in the patients with daily attacks, while it was lower (55% vs 77%) in those with sporadic attacks. All 27 patients with a positive HV also had a positive response to E, while of the five patients with a negative HV, two also had a negative response to E and the other three had a positive E at a higher dose than that of the patients with daily attacks. The incidence of chest pain and of ST-segment elevation or depression or T-wave positivization was similar during the two tests; however, spontaneous remission of ischaemia was more frequent after HV than after E and ventricular arrhythmias less frequent during the HV test. At the onset of myocardial ischaemia pH was significantly higher compared with basal values (7.51 +/- 0.07 vs 7.38 +/- 0.05, P less than 0.001), while double product was not significantly different compared with basal (10.0 +/- 2.4 vs 9.2 +/- 2.1).(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsM Previtali, D Ardissino, C Storti, R D Chimienti, J A Salerno
JournalEuropean heart journal (Eur Heart J) Vol. 10 Suppl F Pg. 101-4 (Nov 1989) ISSN: 0195-668X [Print] England
PMID2515964 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Carbon Dioxide
  • Oxygen
  • Ergonovine
Topics
  • Angina Pectoris, Variant (diagnosis, physiopathology)
  • Blood Pressure
  • Carbon Dioxide (blood)
  • Electrocardiography
  • Ergonovine
  • Female
  • Humans
  • Hydrogen-Ion Concentration
  • Hyperventilation (physiopathology)
  • Male
  • Middle Aged
  • Oxygen (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: